Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
410 studies found for:    Open Studies | "Uterine Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Epidemiology of Uterine Cancer in Taiwan
Condition: Uterine Cancers
Intervention: Other: Histologic types
2 Recruiting Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Conditions: Uterine Cancer;   Cervical Cancer
Intervention: Radiation: Proton radiation therapy
3 Recruiting Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast and Cervical/Uterine Cancer Patients
Conditions: Head and Neck Cancer;   Melanoma;   Breast Cancer;   Cervical Cancer;   Uterine Cancer
Intervention: Drug: fluorescent cRGDY-PEG-Cy5.5-C dots
4 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
5 Unknown † Sentinel Node Biopsy in Endometrial Cancer
Conditions: Uterine Neoplasms;   Sentinel Lymph Node Biopsy
Intervention: Procedure: Sentinel Lymph Node Biopsy
6 Not yet recruiting Sentinel Node Mapping in Women With Cervical and Endometrial Cancer
Conditions: Uterine Cervical Neoplasms;   Uterine Neoplasms
Intervention: Procedure: Sentinel lymph node mapping
7 Not yet recruiting Sentinel Node Mapping in Women With High Risk Endometrial Cancer and Cervical Cancer
Conditions: Uterine Cervical Neoplasms;   Uterine Neoplasms
Intervention: Procedure: SLN mapping and removal of PET-positive lymph nodes
8 Recruiting MRI and Metabolomics Biomarkers for Uterine Malignancy
Condition: Uterine Neoplasms
Intervention:
9 Recruiting Biobehavioral Intervention in Gynecologic Oncology Patients
Conditions: Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Vulva
Intervention: Behavioral: BBI intervention
10 Recruiting Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Conditions: Uterine Neoplasms;   Endometrial Neoplasms
Intervention:
11 Recruiting The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection
Condition: Uterine Cancer
Interventions: Drug: Dexmedetomidine group;   Drug: Control group
12 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
13 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
14 Recruiting A Mind-body Intervention to Improve Body and/or Self Image
Conditions: Breast Cancer;   Ovarian Cancer;   Uterine Cancer;   Cervical Cancer
Interventions: Behavioral: Hypnotic Relaxation Therapy;   Behavioral: Progressive Muscle Relaxation
15 Recruiting A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
Conditions: Endometrial Cancer;   Uterine Cancer;   Cervical Cancer
Intervention: Device: PINPOINT
16 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
17 Recruiting Cancer of the Uterus and Treatment of Stress Urinary Incontinence
Conditions: Endometrial Cancer;   Stress Urinary Incontinence
Intervention:
18 Recruiting Prospective Analysis of Robot-Assisted Surgery
Conditions: Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Rectal Cancer;   Bladder Cancer;   Prostate Cancer;   Renal Cancer;   Uterus Cancer;   Head and Neck Cancer;   Lung Cancer
Interventions: Procedure: Robot-assisted surgery;   Procedure: Conventional Surgery
19 Not yet recruiting Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Conditions: Cervical Cancer;   Ovarian Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulval Cancer;   Psychosexual Dysfunctions
Intervention: Behavioral: SAFFRON stepped care
20 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years